A systematic review of the effectiveness of adalimumab

171. Geborek P, Crnkic M, Petersson IF, Saxne T, South
Swedish Arthritis Treatment Group. Etanercept,
infliximab, and leflunomide in established
rheumatoid arthritis: clinical experience using a
structured follow up programme in southern
Sweden. Ann Rheum Dis 2002;61:793–8.
172. Wiles NJ, Lunt M, Barrett EM, Bukhari M,
Silman AJ, Symmons DPM, et al. Reduced
disability at five years with early treatment of
inflammatory polyarthritis. Results from a large
observational cohort, using propensity models to
adjust for disease severity. Arthritis Rheum 2001;
44:1033–42.
173. Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP,
Dawes PT, Gömör B. A comparison of the efficacy
and safety of leflunomide and methotrexate for
the treatment of rheumatoid arthritis.
Rheumatology 2000;39:655–65.
174. Bresnihan B, Alvaro-Gracia JM, Cobby M,
Doherty M, Domljan Z, Emery P. Treatment of
rheumatoid arthritis with recombinant human
interleukin-1 receptor antagonist. Arthritis Rheum
1998;41:2196–204.
175. Zeidler HK, Kvien TK, Hannonen P, Wollheim FA,
Forre O, Geidel H. Progression of joint damage in
early active severe rheumatoid arthritis during
18 months of treatment: comparison of low-dose
cyclosporin and parenteral gold. Br J Rheumatol
1998;37:874–82.
176. Kvien TK, Zeidler HK, Hannonen P, Wollheim FA,
Forre O, Hafstrom I, et al. Long term efficacy and
safety of cyclosporin versus parental gold in early
rheumatoid arthritis: a three year study of
radiographic progression, renal function, and
arterial hypertension. Ann Rheum Dis 2002;
61:511–16.
177. HERA Study Group. A randomised trial of
hydroxychloroquine in early rheumatoid arthritis.
Am J Med 1995;98:168.
178. Kalden JR, Scott DL, Smolen JS,
Schattenkirchner M, Rozman B, Williams BD, et al.
Improved functional ability in patients with
rheumatoid arthritis – long-term treatment with
leflunomide versus sulfasalazine. J Rheumatol 2001;
28:1983–91.
179. Smolen JS, Kalden JR, Scott DL, Rozman B,
Kvien TK, Larsen A, et al. Efficacy and safety of
leflunomide compared with placebo and
sulphasalazine in active rheumatoid arthritis: a
double-blind, randomised, multicentre trial. Lancet
1999;353:259–66.
180. Gerards AH, Landewe RB, Prins AP, Bruyn GA,
Goei The HS, Laan RF, et al. Cyclosporin A
monotherapy versus cyclosporin A and
methotrexate combination therapy in patients with
early rheumatoid arthritis: a double blind
© Queen’s Printer and Controller of HMSO 2006. All rights reserved.
Health Technology Assessment 2006; Vol. 10: No. 42
randomised placebo controlled trial. Ann Rheum
Dis 2003;62:291–6.
181. Willkens RF, Sharp JT, Stablein D, Marks C,
Wortmann R. Comparison of azathioprine,
methotrexate, and the combination of the two in
the treatment of rheumatoid arthritis. Arthritis
Rheum 1995;38:1799–806.
182. Yocum DE, Allard S, Cohen SB, Emery P, Flipo RM,
Goobar J, et al. Microemulsion formulation of
cyclosporin (Sandimmun Neoral) vs Sandimmun:
comparative safety, tolerability, and efficacy in
severe acute rheumatoid arthritis. Rheumatology
2000;39:156–64.
183. Marra CA, Esdaile JM, Guh D, Fisher JH,
Chalmers A, Anis AH. The effectiveness and
toxicity of cyclosporin A in rheumatoid arthritis:
longitudinal analysis of a population-based
registry. Arthritis Care and Research 2001;
45:240–5.
184. Hamilton J, McInnes IB, Thomson EA, Porter D,
Hunter JA, Madhok R, et al. Comparative study of
intramuscular gold and methotrexate in a
rheumatoid arthritis population from a socially
deprived area. Ann Rheum Dis 2001;60:566–72.
185. Furst D, Lindsley H, Baethge B, Botstein GR,
Caldwell J, Dietz F, et al. Dose-loading with
hydroxychloroquine improves the rate of response
in early, active rheumatoid arthritis. Arthritis Rheum
1999;42:357–65.
186. Van Roon EN, Jansen TLT, Mourad L,
Houtman PM, Bruyn GAW, Griep EN, et al.
Leflunomide in active rheumatoid arthritis: a
prospective study in daily practice. Br J Clin
Pharmacol 2004;58:201–8.
187. Proudman SM, Conaghan PG, Richardson C,
Griffiths B, Green MJ, McGonagle D, et al.
Treatment of poor prognosis early rheumatoid
arthritis. A randomised study of treatment with
methotrexate, cyclosporin A, and intraarticular
cortiocosteroids compared with sulphasalaszine
alone. Arthritis Rheum 2000;43:1809–19.
188. Edwards CJ, Arden NK, Fisher D, Saperia JC,
Reading I, van Staa TP, et al. The changing use of
disease-modifying anti-rheumatic drugs in
individuals with rheumatoid arthritis from the
United Kingdom General Practice Research
Database. Rheumatology 2005;44:1394–8.
189. Tugwell P, Pincus T, Yocum D, Stein M, Gluck O,
Kraag G, et al. Combination therapy with
cyclosporine and methotrexate in severe
rheumatoid arthritis. N Engl J Med 1995;
333:137–41.
190. Gerards A, Landewe R, Prins A, Bruijn G,
Goei T, Dijkmans B. Combination therapy with
cyclosporin A and methotrexate in patients with
early aggressive rheumatoid arthritis,
135